Search

DIAGNOSIS ONLINE

Find out your possible Diagnosis and Receive your Care Plan
in just a few clicks!

DIAGNOSIS ONLINE

Find out your possible Diagnosis and Receive your Care Plan
in just a few clicks!

icon nevia Ochema

OCHEMA
APP

The App that guides you successfully
In the treatment of your Rhinosinusitis!

icon nevia Ochema

OCHEMA APP

The App that successfully guides you in the treatment of your Rhinosinusitis!

our therapeutic areas

We are a pharmaceutical company focused in the respiratory field. Our mission is the research, development and production of unique and innovative pharmaceutical products. We specialize in the treatment of: Rhinosinusitis, Otitis Media with Effusion (OME) and Recurrent Respiratory Infections (IRR).

THERAPEUTIC AREAS

Recurrent
Respiratory
Infections.

THERAPEUTIC AREAS

Rhinosinusitis


THERAPEUTIC AREAS

Otitis
Media
with Effusion.

The products of our pharmaceutical company,
unique in the market and patented.

We have several innovative products already available on the market, and others in research, development, or in clinical trials. The drugs already available are indicated in respiratory diseases, especially for: Rhinosinusitis, Otitis Media with Effusion, and Recurrent Respiratory Infections.

You are a Physician or a Pharmacist? Log in to the private area and discover the benefits reserved to you!

CiliaCell spray nasale

CILIACELL

THE ONLY
PRODUCT ON THE MARKET ABLE TO ACT EFFECTIVELY ON THE REAL CAUSES OF RHINOSINUSITIS!

There are many drugs on the market used to treat rhinosinusitis, which almost always act only on symptoms, except for antibiotics that act on bacterial infections but are not effective against viral infections (which account for 85 percent of the etiological agents responsible for rhinosinusitis) and fungal infections.

A specific product for the treatment of rhinosinusitis should act simultaneously on the three clinical characterizations of the same rhinopathies, namely: nasosinusal mucosal edema, altered pneumatisation of the sinuses, reduction or loss of mobility and ciliary motility as well as accumulation of muco-purulent secretions in the nasosinusal area and in the auditory tubes.

Ciliacell is the only product specifically designed to effectively treat rhinosinusitis characterized by the above clinical manifestations, namely:
nasosinusal mucosal edema, altered pneumatisation of the sinuses, reduction or loss of mobility and ciliary motility as well as accumulation of muco-purulent secretions in the nasosinusal area and in the auditory tubes.

Ciliacell is a patent-protected product of Nevia Biotech and has been tested in several internationally prominent clinical trials.

The demonstrated clinical healing efficacy is more than 90%.

CILIACELL

THE ONLY PRODUCT ON THE MARKET
ABLE TO ACT EFFECTIVELY
ON THE REAL CAUSES OF RHINOSINUSITIS!

There are many drugs on the market used to treat rhinosinusitis, which almost always act only on symptoms, except for antibiotics that act on bacterial infections but are not effective against viral infections (which account for 85 percent of the etiological agents responsible for rhinosinusitis) and fungal infections.

A specific product for the treatment of rhinosinusitis should act simultaneously on the three clinical characterizations of the same rhinopathies, namely: nasosinusal mucosal edema, altered pneumatisation of the sinuses, reduction or loss of mobility and ciliary motility as well as accumulation of muco-purulent secretions in the nasosinusal area and in the auditory tubes.

Ciliacell is the only product specifically designed to effectively treat rhinosinusitis characterized by the above clinical manifestations, namely:
nasosinusal mucosal edema, altered pneumatisation of the sinuses, reduction or loss of mobility and ciliary motility as well as accumulation of muco-purulent secretions in the nasosinusal area and in the auditory tubes.

Ciliacell is a patent-protected product of Nevia Biotech and has been tested in several internationally prominent clinical trials.

The demonstrated clinical healing efficacy is more than 90%.

CiliaCell spray nasale

Discover the Group

NEVIA |

BIOTECH |

We are a Swiss-Italian corporate group with head quarters in Lugano (Switzerland) and Montella AV (Italy), engaged in Research, Development, Production and Commercialization of innovative pharmaceutical products in the respiratory field, particularly for rhinosinusitis.

Our strength is to possess some unique pharmaceutical products, characterized by efficacy and safety in their use, all proven with relevant clinical studies.

RESEARCH AND DEVELOPMENT |

Innovative products already on the market, and others under development or in clinical trials.

SEARCH

AND DEVELOPMENT. |

Innovative products already on the market, and others under development or in clinical trials.

Research and Development

The beating heart of Nevia Biotech

The research and development area is the beating heart of our pharmaceutical company. Almost all of the products on the market, in fact, come from the company’s research and development, focused mainly on creating new drugs in rheumatology and neuropsychiatry, as well as, of course, in the respiratory field.

At present, Nevia Biotech has some very important research and development projects, such as:

  • Development of a new pharmaceutical product for the treatment of non-allergic cell-mediated rhinitis Nares, Narma, Narne, Naresma (the only product in the world specifically for the treatment of these nosological entities)
  • Development of new drugs for the treatment of pre-eclampsia, fibromyalgia and A.D.H.D.

Clinical Research

CiliaCell, a unique product for rhinosinusitis and otitis

The most important products in our company list at the moment are those of the CiliaCell line, which are specific and unique in the world for the treatment of chronic rhinosinusitis and otitis media with effusion, both in adults and pediatric age.

Several clinical studies have already been conducted for these products and published in top scientific journals in the field.

The Research and Development Pipeline
of our pharmaceutical company.

The research and development pipeline of our pharmaceutical company includes several therapeutic areas, such as:
Respiratory, Rheumatology, Child Neuropsychiatry.

Riniti vasomotorie Non Allergiche cellulo-mediate

Non-allergic vasomotor rhinitis, among chronic rhinopathies, represents an area…

A.D.H.D. (deficit di attenzione e iperattività)

Attention Deficit Disorder with Hyperactivity Disorder (ADHD, an acronym for the English…

Sindrome fibromialgica

The word fibromyalgia (FM) comes from the Latin fibre, which stands for the tissues…

TRADE
WHOLESALE.
OF DRUGS.

Nevia Biotech is a pharmaceutical company licensed by Swissemedic for:

  • Imports of medicines
  • Wholesale of medicines
  • Export of medicines
  • Foreign trade in medicines

We are able to source and supply any kind of drugs globally, including: drugs lacking in different countries, orphan drugs, oncology drugs, vaccines, chemotherapeutics, etc.

DOWNLOAD DRUG LIST

By way of example, but not limited to, the list of drugs we can provide: see drug list

DID YOU KNOW.

MEDICAL OR
PHARMACIST?

Access the area
dedicated

NEW

RHINOSINUSITE?

Perform
the Diagnosis
Online

100% Safe Shipping.
We protect and insure
compliance of products.

Available for your health.

We are at your complete disposal for any eventualities or information.
Just send us an email or contact us through the dedicated form, we will answer your questions as soon as possible.

Stay Updated!
Sign up for the newsletter.

Sign up for the Newsletter, receive our offers, pharmaceutical news and promotions from Nevia Biotech before anyone else.

Product has been added to your cart